Active prevention in diabetic eye disease: A 4‐year follow‐up
The DOI matches its Crossref record.
Abstract
Ten years after the foundation of a national diabetic eye screening program in 1980, we have established a low prevalence of blindness and partial sight in type 1 and type 2 diabetics in Iceland. We ask whether the screening program is also associated with a low incidence of blindness in diabetics. We now report the results of a prospective study on the 4‐year incidence of diabetic retinopathy and visual impairment in type 1 diabetics with age at onset less than 30 years. Out of 205 patients participating at baseline, 175 patients (85.4%) participated over the full 4‐year period. Patients were examined annually and received laser treatment according to Diabetic‐ and Early Treatment Diabetic Retinopathy Study criteria. The 4‐year incidence of any retinopathy was 38.1%, of proliferative retinopathy 6.6%, and of macular edema 3.4%. Out of 174 patients, 7.4% showed improvement in visual acuity of 2 Snellen lines while 2.5% experienced worsening of visual acuity of 2 Snellen lines during the 4‐year period. No diabetic suffered more than 2 lines deterioration of vision and none became legally blind. The incidence of retinopathy in Icelandic type 1 diabetics participating in our annual eye screening program is low and the visual acuity stable. Our results suggest that visual impairment in diabetics can be prevented with active regular screening and standard laser therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Screening for diabetic retinopathy: new perspectives and challenges
Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, P., Peto, T., & Simó, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30411-5 · Cited by 671
A deep learning system for detecting diabetic retinopathy across the disease spectrum
Dai, L., Wu, L., Li, H., Cai, C., Wu, Q., Kong, H., Liu, R., Wang, X., Hou, X., Liu, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23458-5 · Cited by 620
“In the United Kingdom and Iceland, where systematic national DR screening has been carried out, DR is no longer the leading cause of blindness among working-age adults 4,5 .”
BackgroundEpidemiology of diabetic retinopathy and macular oedema: A systematic review
Williams, R., Airey, M., Baxter, H., Forrester, J., Kennedy-Martin, T., & Girach, A. (2004) · Eye · doi:10.1038/sj.eye.6701476 · Cited by 472
5-year incidence of age-related maculopathy in the Reykjavik Eye Study
JONASSON, F., ARNARSSON, A., PETO, T., SASAKI, H., SASAKI, K., & BIRD, A. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.07.020 · Cited by 64
Metadata
- Authors
- Kristinsson, J. K., Hauksdóttir, H., Stefánsson, E., Jónasson, F., & Gíslason, I.
- Venue
- Acta Ophthalmologica Scandinavica
- Publisher
- Wiley
- Published
- 1997-06
- Volume
- 75
- Issue
- 3
- Pages
- 249-254
- ISSN
- 1395-3907 (ISSN-L)
- 1600-0420
- OpenAlex
- W1985585773
- Cited by
- 50
- References
- 0
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Active prevention in diabetic eye disease: A 4‐year follow‐up. https://app.cochat.ai/papers/10.1111/j.1600-0420.1997.tb00766.x
- The paper
- Kristinsson, J. K., Hauksdóttir, H., Stefánsson, E., Jónasson, F., & Gíslason, I. (1997). Active prevention in diabetic eye disease: A 4‐year follow‐up. Acta Ophthalmologica Scandinavica. https://doi.org/10.1111/j.1600-0420.1997.tb00766.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.